Developing a new imaging tool for a brain receptor linked to autism
PET ligand discovery for arginine vasopressin
This study is working on a new imaging tool to help us see how a specific brain receptor linked to autism spectrum disorder works, which could lead to better treatments for those with ASD.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11080264 on NIH RePORTER |
What this research studies
This research focuses on creating a novel PET ligand specifically for the V1A arginine vasopressin receptor, which has been associated with autism spectrum disorder (ASD). By developing this imaging tool, researchers aim to better understand how this receptor functions in the brain and its role in ASD. The study will utilize advanced imaging techniques to quantify the receptor's activity in living subjects, providing insights that traditional methods cannot achieve. This could lead to improved therapeutic strategies targeting the underlying mechanisms of ASD.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with autism spectrum disorder who may benefit from new therapeutic approaches targeting the V1A receptor.
Not a fit: Patients without a diagnosis of autism spectrum disorder or those who do not have any related neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of autism and lead to more effective treatments for individuals with ASD.
How similar studies have performed: While there have been advancements in imaging techniques for other receptors, this specific approach to imaging the V1A receptor in relation to autism is novel and has not been previously demonstrated.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Liang, Steven H — Emory University
- Study coordinator: Liang, Steven H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.